These ETFs Could Benefit From the Latest Pharma Takeover Rumor

The health care sector was one of the busiest in terms of mergers and acquisitions activity last year with the pharmaceuticals industry seeing the bulk of the activity. Conventional wisdom dictates that cash-rich blue chip pharmaceuticals firms facing patent cliffs will use some of that cash to...